Showing results (421-430 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|December 2, 2024
Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction-associated steatohepatitisMichelle Lai, Simon T Dillon, Xuesong Gu, et al.
Hepatology Communications|December 2, 2024
The pyruvate dehydrogenase kinase inhibitor dichloroacetate mitigates alcohol-induced hepatic inflammation and metabolic disturbances in miceJianguo Wu, Emily Huang, Megan R McMullen, et al.
Hepatology Communications|November 4, 2024
National Liver Cancer Screening Trial (TRACER) study protocolAmit G Singal, Neehar D Parikh, Fasiha Kanwal, et al.
Hepatology Communications|November 4, 2024
A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction-associated steatotic liver diseaseLaura S Grinshpan, Yaara Even Haim, Dana Ivancovsky-Wajcman, et al.
Hepatology Communications|October 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology Communications|May 12, 2026
Symptom burden and treatment patterns in primary biliary cholangitis: A systematic review and meta-analysisAmbrose Hon-Lam Chung, Jarell Jie-Rae Tan, Roe Xin Jacqueline Yap, et al.
Hepatology Communications|May 22, 2026
Reduced wait times for hepatology referrals in a prospective quality improvement initiativeOfodile Joe-Uzuegbu, Yashasavi Sachar, Abdel Aziz Shaheen, et al.
Hepatology Communications|March 11, 2026
The rate and predictors of recompensation in patients with decompensated cirrhosis due to metabolic dysfunction-associated liver disease (MASLD)Alba Jiménez-Masip, M Teresa Broquetas, Sergio Muñoz-Martinez, et al.
Hepatology Communications|March 13, 2026
The dual roles of natural killer cells in liver immunity and tolerance: Implications for health and diseaseZhongheng Li, Yihang Gong, Linsen Ye, et al.
Hepatology Communications|May 23, 2025
VLDL lipidomics reveals hepatocellular lipidome changes in metabolic dysfunction-associated steatotic liver diseaseDavid Guardamino Ojeda, Yusuf Yalcin, Yered Pita-Juarez, et al.
Pageof 179